Luminii provides Commercial Due Diligence support to Imbiba on its investment in Pindrop Hearing
Luminii are delighted to have provided Commercial Due Diligence (CDD) to Imbiba Growth LLP (Imbiba) on its recent investment in Pindrop Hearing Limited (Pindrop), a leading private clinical audiology business.
Founded by Dr Rony Ganguly, Pindrop Hearing has built an outstanding reputation for clinical excellence and patient-centred care. Since opening its flagship Harley Street clinic in 2017, the business has combined evidence-based audiology with exceptional service, developing strong referral relationships with GPs, ENT consultants and private medical networks.
Today, Pindrop operates three premium clinics across Harley Street, Chelsea and Winchmore Hill, providing advanced diagnostics, vestibular services and unbiased hearing aid provision across all major manufacturers. With their investment, Imbiba will support the next phase of growth, helping expand the clinic network across London and the South of England, whilst strengthening the clinical and operational team to support a multi-site platform.
Jonathan Gardner, former Managing Director of Boots Hearingcare, will join as Chairperson. Jonathan led the rapid scale-up of Boots Hearingcare from 100 to 500 rooms, during both the KKR and Walgreens ownerships.
He has since held CEO roles in multiple private equity-backed healthcare platforms, including KKR-backed businesses, bringing significant experience in roll-out strategy and value creation.
In addition to Jonathan, Imbiba’s Heidi Duckworth and Andrew Guest will join the board alongside Royston Guest, who has advised Pindrop on growth strategy for a number of years.
“Pindrop represents a truly premium clinical platform in a structurally growing market. Rony has built an outstanding reputation for clinical excellence and patient care. We believe there is a significant opportunity to roll out this model into other locations, delivering unbiased, customer-centric audiology services of the highest quality.” - Heidi Duckworth, Partner, Imbiba
“We have always focused on providing the highest standards of clinical audiology, centred around patient care and independence. Partnering with Imbiba allows us to accelerate our expansion, bringing our model to more communities while maintaining the standards that define Pindrop.” - Dr Rony Ganguly, Founder and CEO, Pindrop Hearing
"Luminii are delighted to have supported Imbiba on this transaction. This is yet another deal that helps to strengthen our credentials in the healthcare sector. We extend our best wishes to Imbiba and Pindrop for continued success in the future." - Lushani Kodituwakku, Managing Director, Luminii Consulting
Latest articles
- Luminii provides Commercial Due Diligence support to FPE Capital and Point74 on its acquisition of Quor System 27 Mar 2026
- Luminii provides Commercial Due Diligence support to Imbiba on its investment in Pindrop Hearing 26 Mar 2026
- Learning from the Six Nations, NFL, and Football: Can Domestic Rugby Create a Platform for Investment? 05 Mar 2026
- UK Dental Lab Market Enters New Era as Technology and Investment Reshape the Industry 20 Feb 2026
- Luminii provides CDD to Palatine and Papilo on their acquisition of Allwood Recycling Solutions 06 Feb 2026






























